The ₹25-crore rights issue of Krebs Biochemicals & Industries will open for subscription on Wednesday and end on March 15. The company is offering 21 shares for every 100 held to its existing shareholders at ₹75 share. Krebs Biochemicals had set February 1 as the record date to identify eligible shareholders for the rights issue. The stock will remain in focus, as it closed at ₹87 on the NSE. At the end of December 2018, 4,706 small retail invesotrs hold 11.31 per cent stake.
What to watch. Krebs Biochemicals rights issue opens today
Published on
February 27, 2019 00:00
Tags